Comparison of mean differences in temperature decreases. by Hans-Jörg Gillmann (8460585)

PV1-treated mice exhibited a decrease in overall activation of T lymphocytes. by Pedro Henrique Papotto (791904)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)

h-GAAP Decreases Cell Susceptibility to Extrinsic Apoptosis Pathways by Caroline Gubser (24818)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

LPS decreases only T cell proliferative response to OKT3. by Fanny Poujol (834338)

2-APB decreased the expression of maturation markers in human DC. by Romain Félix (586765)

NE inhibits macrophage migration by decreasing CCR2 expression. by Fangming Xiu (315046)

Lethal toxin decreases IL-22 production in human ILCs. by Sudarshan Seshadri (370894)

Adoptive transfer of mature NK cells decreases the incidence of BA and improves survival, and the level of VP4 in cholangiocytes and the incidence of BA are decreased as the age of... by Yinrong Qiu (345978)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

<i>In vitro</i> 95% CI lower and upper mean susceptibility responses of field isolates to antimalarials. by Winnie Okore (14139712)

Subjects:

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

IL-1Ra expressed by MSCs decreased Th17 differentiation. by Kijun Lee (4888660)

Increased miR200c decreases FAP-1 expression. by Sabarinathan Ramachandran (444500)

<i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays. by Ling Tian (107492)

“…The most striking difference was found in KO-F mice (35.51-fold increase in SLAM cells as compared to KO-F CD45.2⁺ donor cells in whole BM, p = 0.0430). …”

Mean change in incidence and diagnoses if testing rates decrease. by Richard T. Gray (282417)

“…<p>Change in incidence (A) and diagnoses (B) if testing rates decrease by 30% and 50% relative to the current testing rate.…”

T310A mutation decreases TSP50’s ability to interact with NF-κB:IκBα complex and to promote NF-κB signaling. by Yu-Yin Li (323887)

Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

“…Notably, miR-155, a known regulator of liver inflammation, had the highest fold increase in cirrhotic livers (2.2-fold, P=4.16E-08) and significantly correlated with hepatic CYP3A activity (r=-0.50, P=0.017). …”